Paradigm Biopharmaceuticals Ltd

NEW
OTCPK:PBIGF (Australia)  
$ 0.38 (0%) 12:08 AM EST
At Loss
P/B:
7.21
Market Cap:
$ 118.90M
Enterprise V:
$ 103.58M
Volume:
-
Avg Vol (2M):
9.38K
Trade In:
Volume:
-
At Loss
Avg Vol (2M):
9.38K

Business Description

Description
Paradigm Biopharmaceuticals Ltd is a late-stage clinical development company engaged in the research and development of therapeutic products for human use in Australia. The firm is engaged in developing injectable pentosan polysulphate sodium (iPPS) for the treatment of pain associated with musculoskeletal disorders driven by injury, inflammation, aging, degenerative disease, infection, or genetic predisposition. The company has registered the trademarks Zilosul and Rhinosul for the commercialization of iPPS.
Name Current Vs Industry Vs History
Cash-To-Debt 74.57
Equity-to-Asset 0.87
Debt-to-Equity 0.01
Piotroski F-Score 5/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 14.52
Distress
Grey
Safe
Beneish M-Score -1.74
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 7.22
Quick Ratio 7.22
Cash Ratio 5.3
Days Payable 303801.67

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -13.7
Shareholder Yield % -14.76

Financials (Next Earnings Date:2025-04-30 Est.)

PBIGF's 30-Y Financials
Income Statement Breakdown FY
Not Enough Data
Balance Sheet Breakdown
Not Enough Data
Cashflow Statement Breakdown
Not Enough Data

Operating Revenue by Business Segment

Operating Revenue by Geographic Region

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
Not Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with OTCPK:PBIGF

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016

Paradigm Biopharmaceuticals Ltd Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0.044
EPS (TTM) ($) -0.133
Beta 0.43
3-Year Sharpe Ratio -0.15
3-Year Sortino Ratio -0.26
Volatility % 104.87
14-Day RSI 92.6
14-Day ATR ($) 0.004587
20-Day SMA ($) 0.35156
12-1 Month Momentum % 40.65
52-Week Range ($) 0.1147 - 0.3807
Shares Outstanding (Mil) 389.43

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 5
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Paradigm Biopharmaceuticals Ltd Filings

Filing Date Document Date Form
No Filing Data

Paradigm Biopharmaceuticals Ltd Stock Events

Financials Calendars
Event Date Price ($)
No Event Data

Paradigm Biopharmaceuticals Ltd Frequently Asked Questions

What is Paradigm Biopharmaceuticals Ltd(PBIGF)'s stock price today?
The current price of PBIGF is $0.38. The 52 week high of PBIGF is $0.38 and 52 week low is $0.11.
When is next earnings date of Paradigm Biopharmaceuticals Ltd(PBIGF)?
The next earnings date of Paradigm Biopharmaceuticals Ltd(PBIGF) is 2025-04-30 Est..
Does Paradigm Biopharmaceuticals Ltd(PBIGF) pay dividends? If so, how much?
Paradigm Biopharmaceuticals Ltd(PBIGF) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1